4. Belmaker RH, Agam G. Major depression disorder. N Engl J Med 2008;358:55-68.
6. Bukh JD, Bock C, Werge T, Gether U, Vedel Kessing L. Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 2009;119:107-115.
8. Evrensel A, Ünsalver BÖ, Ceylan ME. Psychobiotics. In: Kim YK, Editor. Frontiers in Psychiatry. Advances in Experimental Medicine and Biology. 1192. Singapore: Springer; 2019, p. 565-581.
9. Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th Ed. New York: Cambridge University Press; 2013.
10. Pytka K, Dziubina A, Mlyniec K, Dziedziczak A, Zmudzka E, Furgala A, et al. The role of glutamatergic, gaba-ergic, and cholinergic receptors in depression and antidepressant-like effect. Pharmacol Rep 2016;68:443-450.
12. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004;29:185-193.
15. Seferovic MD, Pace RM, Caroll M, Belfort B, Major AM, Chu DM, et al. Visualization of microbes by 16s in situ hybridization in term and preterm placentae without ıntraamniotic ınfection. Med Sci (Basel) 2019;7:21
17. Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol 2014;817:177-194.
18. Bien-Ly N, Watts RJ. The blood-brain barrier’s gut check. Sci Transl Med 2014;6:263fs46.
19. Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF, O’leary OF. Adult hippocampal neurogenesis ıs regulated by the microbiome. Biol Psychiatry 2015;78:e7-e9.
21. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 2015;48:186-194.
22. Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol 2016;14:1602-1611.
23. Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, et al. Possible association of bifidobacterium and lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 2016;202:254-257.
25. Yu M, Jia H, Zhou C, Yang Y, Zhao Y, Yang M, et al. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics. J Pharm Biomed Anal 2017;138:231-239.
26. Lin P, Ding B, Feng C, Yin S, Zhang T, Qi X, et al. Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord 2017;207:300-304.
28. Kelly JR, Borre Y, O’brien C, Patterson E, El Aidy S, Deane J, et al. Transferring the blues: Depression-associated gut microbiota ınduces neurobehavioural changes in the rat. J Psychiatr Res 2016;82:109-118.
29. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1260-1344.
30. Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B. Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry 2015;76:1522-1528.
32. Bercik P, Collins SM. The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Adv Exp Med Biol 2014;817:279-289.
33. Kohler O, Petersen L, Mors O, Mortensen PB, Yolken RH, Gasse C, et al. Infections and exposure to anti-ınfective agents and the risk of severe mental disorders: A nationwide study. Acta Psychiatr Scand 2017;135:97-105.
34. Slykerman RF, Thompson J, Waldie KE, Murphy R, Wall C, Mitchell EA. Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr 2017;106:87-94.
37. Oriach CS, Robertson RC, Stanton C, Cryan JF, Dinan TG. Food for thought: the role of nutrition in the microbiota-gut-brain axis. Clin Nutr Exp 2016;6:25-38.
38. Owen L, Corfe B. The role of diet and nutrition on mental health and wellbeing. Proc Nutr Soc 2017;76:425-426.
39. Slyepchenko A, Maes M, Jacka FN, Köhler CA, Barichello T, McIntyre RS, et al. Gut microbiota, bacterial translocation, and ınteractions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities. Psychother Psychosom 2017;86:31-46.
40. Noble EE, Hsu TM, Kanoski SE. Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive ımpairment. Front Behav Neurosci 2017;1:9
42. Carvalho LA, Torre JP, Papadopoulos AS, Poon L, Juruena MF, Markopoulou K, et al. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord 2013;148:136-140.
45. Woelfer M, Kasties V, Kahlfuss S, Walter M. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience 2019;403:93-110.
46. Song C, Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:760-768.
49. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O’Neil A, et al. Oxidative and nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 2014;45:46-62.
51. Raison CL. Inflammatory depression: a trifecta of trouble. J Clin Psychiatry 2014;75:663-664.
53. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta- analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457.
54. Smith RS. The macrophage theory of depression. Med Hypotheses 1991;35:298-306.
55. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive dis- order: a meta-analysis and meta-regression. J Affect Disord 2012;139:230-239.
56. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2012;2:e199
57. Rawdin B, Mellon S, Dhabhar F, Epel ES, Puterman E, Su Y, et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 2013;31:143-152.
58. Krogh J, Benros ME, Jørgensen MB, Vesterager L, Elfving B, Nordentoft M. The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav Immun 2014;35:70-76.
59. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacol 2000;22:370-379.
60. O’Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004;19:397-403.
61. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 2018;23:716-724.
62. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008;29:117-124.
64. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: a review. Brain Behav Immun 2017;66:9-17.
67. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: Diet, microbiome, and neuropsychiatry. Transl Res 2017;179:223-244.
69. Bollrath J, Powrie F. Immunology. Feed your Tregs more fiber. Science 2013;341:463-464.
70. Dinan TG, Stanton C, Cryan JF. Psychobiotics: A novel class of psychotropic. Biol Psychiatry 2013;74:720-726.
71. Phillips JGP. The treatment of melancholia by the lactic acid bacillus. Br J Psychiatry 1910;56:422-431.
72. Pirbaglou M, Katz J, De Souza RJ, Motamed M, Ritvo P. Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials. Nutr Res 2016;36:889-898.
74. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 2015;310:561-577.
75. Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 2016;32:315-320.
76. Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology 2017;79:40-48.
77. Evrensel A, Ceylan ME. Fecal Microbiota Transplantation in the Treatment-Resistant Psychiatric Disorders. In: Kim YK, editor. Treatment Resistance in Psychiatry. Singapore: Springer, 2019, p. 369-376.
78. Evrensel A, Kılıçaslan S. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with inflammatory bowel disease: an experimental study. Actas Esp Psiquiatr 2019;[Epub ahead of print].
79. Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectrums 2018;23:187-191.
80. Macedo D, Filho A, Soares De Sousa CN, Quevedo J, Barichello T, Junior HVN, et al. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible ımplications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord 2017;208:22-32.
82. Ng QX, Peters C, Ho CYX, Lim DY, Yeo WS. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord 2018;228:13-19.